Related content

Iodine‐123 BMIPP Scintigraphy in the Evaluation of Patients with Heart Failure

By Nakae I.   Matsuo S.   Koh T.   Mitsunami K.   Horie M.  

Acta Radiologica, Vol. 47, Iss. 8, 2006-10 ,pp. : 810-816

Blackwell Publishing

Access to resources Recommend Favorite

I-123-mIBG myocardial imaging for assessment of risk for a major cardiac event in heart failure patients: insights from a retrospective European multicenter study

By Agostini Denis   Verberne Hein   Burchert Wolfgang   Knuuti Juhani   Povinec Pavol   Sambuceti Gianmario   Unlu Mustafa   Estorch Montserrat   Banerjee Gopa   Jacobson Arnold  

European Journal of Nuclear Medicine and Molecular Imaging, Vol. 35, Iss. 3, 2008-03 ,pp. : 535-546

Springer Publishing Company

Access to resources Recommend Favorite

Significance of I-123 metaiodobenzylguanidine (¹²³I-MIBG) lung activity in subjects with heart failure in comparison to healthy control subjects

By Gerson Myron   Dwivedi Alok   Abdallah Mouhamad   Shukla Rakesh   Jacobson Arnold  

Journal of Nuclear Cardiology, Vol. 20, Iss. 4, 2013-08 ,pp. : 592-599

Springer Publishing Company

Access to resources Recommend Favorite

Clinical significance of lung iodine-123 metaiodobenzylguanidine uptake assessment in Parkinson’s and heart diseases

By Nakae Ichiro   Hayashi Hideki   Mitsunami Kenichi   Horie Minoru  

Annals of Nuclear Medicine, Vol. 27, Iss. 8, 2013-10 ,pp. : 737-747

Springer Publishing Company

Access to resources Recommend Favorite

Variations in ¹²³I-metaiodobenzylguanidine (MIBG) late heart mediastinal ratios in chronic heart failure: a need for standardisation and validation

By Verberne Hein   Habraken Jan   Eck-Smit Berthe   Agostini Denis   Jacobson Arnold  

European Journal of Nuclear Medicine and Molecular Imaging, Vol. 35, Iss. 3, 2008-03 ,pp. : 547-553

Springer Publishing Company

Access to resources Recommend Favorite